PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

This is a study using a parallel control approach and is expected to recruit 35 volunteers, including 8 prostate cancer patients, 8 neuroendocrine tumour patients, 8 glioma patients, 8 Parkinson's syndrome patients, and 3 normal volunteers, to undergo dual-nuclide PET/CT imaging and to validate the isolation effect and quantitative accuracy of simultaneous dual-nuclide imaging in humans.

NCT Number	NCT06914427
Lead Sponsor	Xijing Hospital
Conditions	Prostatic Neoplasms, Glioma, PARKINSON DISEASE (Disorder)
Enrollment	35 participants
Start Date	2025-03-28
Primary Completion	2027-03-01 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-06